Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 70.59 Billion JPY | 7.51% |
| 2022 | 65.65 Billion JPY | 4.71% |
| 2021 | 62.7 Billion JPY | 5.71% |
| 2020 | 59.31 Billion JPY | -22.95% |
| 2019 | 76.98 Billion JPY | 0.21% |
| 2018 | 76.82 Billion JPY | 5.83% |
| 2017 | 72.58 Billion JPY | 4.3% |
| 2016 | 69.59 Billion JPY | 13.3% |
| 2015 | 61.42 Billion JPY | 10.28% |
| 2014 | 55.7 Billion JPY | 1.33% |
| 2013 | 54.97 Billion JPY | 3.94% |
| 2012 | 52.88 Billion JPY | 5.06% |
| 2011 | 50.34 Billion JPY | 1.7% |
| 2010 | 49.49 Billion JPY | 2.77% |
| 2009 | 48.16 Billion JPY | 4.04% |
| 2008 | 46.29 Billion JPY | -15.05% |
| 2007 | 54.49 Billion JPY | 19.49% |
| 2006 | 45.6 Billion JPY | 4.87% |
| 2005 | 43.48 Billion JPY | 10.42% |
| 2004 | 39.38 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 15.92 Billion JPY | -27.22% |
| 2024 Q2 | 15.36 Billion JPY | -3.51% |
| 2023 Q2 | 17.81 Billion JPY | 24.89% |
| 2023 FY | 70.59 Billion JPY | 7.51% |
| 2023 Q3 | 16.63 Billion JPY | -6.65% |
| 2023 Q4 | 21.87 Billion JPY | 31.53% |
| 2023 Q1 | 14.26 Billion JPY | -25.11% |
| 2022 FY | 65.65 Billion JPY | 4.71% |
| 2022 Q2 | 17.26 Billion JPY | 25.16% |
| 2022 Q1 | 13.79 Billion JPY | -26.31% |
| 2022 Q4 | 19.04 Billion JPY | 22.53% |
| 2022 Q3 | 15.54 Billion JPY | -9.96% |
| 2021 FY | 62.7 Billion JPY | 5.71% |
| 2021 Q4 | 18.72 Billion JPY | 28.21% |
| 2021 Q1 | 13.1 Billion JPY | -25.44% |
| 2021 Q2 | 16.27 Billion JPY | 24.25% |
| 2021 Q3 | 14.6 Billion JPY | -10.31% |
| 2020 FY | 59.31 Billion JPY | -22.95% |
| 2020 Q4 | 17.57 Billion JPY | 29.82% |
| 2020 Q3 | 13.53 Billion JPY | -8.91% |
| 2020 Q2 | 14.86 Billion JPY | 11.34% |
| 2020 Q1 | 13.34 Billion JPY | -40.81% |
| 2019 FY | 76.98 Billion JPY | 0.21% |
| 2019 Q4 | 22.54 Billion JPY | 19.5% |
| 2019 Q3 | 18.86 Billion JPY | -3.59% |
| 2019 Q2 | 19.57 Billion JPY | 22.32% |
| 2019 Q1 | 15.99 Billion JPY | -31.04% |
| 2018 Q1 | 15.7 Billion JPY | -29.21% |
| 2018 Q2 | 19.02 Billion JPY | 21.13% |
| 2018 FY | 76.82 Billion JPY | 5.83% |
| 2018 Q4 | 23.2 Billion JPY | 22.87% |
| 2018 Q3 | 18.88 Billion JPY | -0.77% |
| 2017 Q4 | 22.19 Billion JPY | 21.98% |
| 2017 FY | 72.58 Billion JPY | 4.3% |
| 2017 Q1 | 14.34 Billion JPY | 0.0% |
| 2017 Q2 | 17.86 Billion JPY | 24.56% |
| 2017 Q3 | 18.19 Billion JPY | 1.82% |
| 2016 FY | 69.59 Billion JPY | 13.3% |
| 2016 Q2 | 15.5 Billion JPY | -7.94% |
| 2016 Q3 | 18.09 Billion JPY | 16.66% |
| 2016 Q1 | 16.84 Billion JPY | 4.88% |
| 2015 FY | 61.42 Billion JPY | 10.28% |
| 2015 Q1 | 14.04 Billion JPY | -3.44% |
| 2015 Q4 | 16.06 Billion JPY | 7.32% |
| 2015 Q2 | 13.54 Billion JPY | -3.51% |
| 2015 Q3 | 14.96 Billion JPY | 10.47% |
| 2014 Q4 | 14.54 Billion JPY | 5.13% |
| 2014 Q2 | 13.28 Billion JPY | -6.17% |
| 2014 FY | 55.7 Billion JPY | 1.33% |
| 2014 Q3 | 13.83 Billion JPY | 4.12% |
| 2014 Q1 | 14.15 Billion JPY | -3.3% |
| 2013 Q3 | 13.64 Billion JPY | 8.93% |
| 2013 Q4 | 14.64 Billion JPY | 7.31% |
| 2013 Q2 | 12.52 Billion JPY | 1.06% |
| 2013 Q1 | 12.39 Billion JPY | -11.67% |
| 2013 FY | 54.97 Billion JPY | 3.94% |
| 2012 Q1 | 7.16 Billion JPY | -55.06% |
| 2012 Q2 | 13.36 Billion JPY | 86.68% |
| 2012 Q4 | 14.03 Billion JPY | 7.18% |
| 2012 Q3 | 13.09 Billion JPY | -2.06% |
| 2012 FY | 52.88 Billion JPY | 5.06% |
| 2011 Q2 | 12.58 Billion JPY | 65.44% |
| 2011 Q4 | 15.93 Billion JPY | 8.71% |
| 2011 Q3 | 14.65 Billion JPY | 16.45% |
| 2011 FY | 50.34 Billion JPY | 1.7% |
| 2011 Q1 | 7.6 Billion JPY | -49.64% |
| 2010 Q1 | 6.57 Billion JPY | -56.34% |
| 2010 Q2 | 13.25 Billion JPY | 101.49% |
| 2010 Q3 | 13.52 Billion JPY | 2.04% |
| 2010 FY | 49.49 Billion JPY | 2.77% |
| 2010 Q4 | 15.1 Billion JPY | 11.67% |
| 2009 Q1 | 6.82 Billion JPY | -50.9% |
| 2009 Q3 | 13.58 Billion JPY | 5.07% |
| 2009 Q4 | 15.07 Billion JPY | 10.94% |
| 2009 FY | 48.16 Billion JPY | 4.04% |
| 2009 Q2 | 12.92 Billion JPY | 89.32% |
| 2008 Q4 | 13.9 Billion JPY | 5.77% |
| 2008 FY | 46.29 Billion JPY | -15.05% |
| 2008 Q3 | 13.14 Billion JPY | 0.0% |
| 2007 FY | 54.49 Billion JPY | 19.49% |
| 2006 FY | 45.6 Billion JPY | 4.87% |
| 2005 FY | 43.48 Billion JPY | 10.42% |
| 2004 FY | 39.38 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 141.91 Thousand USD | -49743767.981% |
| Bruush Oral Care Inc. | 1.81 Million USD | -3900104.358% |
| CCA Industries, Inc. | 10.67 Million USD | -660972.391% |
| DSwiss, Inc. | 367.64 Thousand USD | -19202015.072% |
| EOS, Inc. | 966.48 Thousand USD | -7304299.65% |
| Greyson International, Inc. | 20.36 Thousand USD | -346653472.305% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | - USD | -Infinity% |
| Infusion Brands International, Inc. | 14.21 Million USD | -496647.107% |
| Mandom Corporation | 184.34 Million USD | -38196.23% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | 543.89 Thousand USD | -12979635.022% |
| Oliveda International, Inc. | 2.88 Million USD | -2450015.971% |
| PacificHealth Laboratories, Inc. | 3.46 Million USD | -2039220.677% |
| Prosperous Future Holdings Limited | 19.39 Million USD | -363873.023% |
| PURE Bioscience, Inc. | 4.28 Million USD | -1648183.913% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 510.37 Thousand USD | -13832082.219% |
| Sentient Brands Holdings Inc. | 250.95 Thousand USD | -28130391.435% |
| Sunset Capital Assets, Inc. | 202.4 Thousand USD | -34879001.985% |
| The Stephan Co. | 2.69 Million USD | -2621363.052% |
| Turner Valley Oil & Gas, Inc. | 145 Thousand USD | -48685789.257% |
| Winning Brands Corporation | 327.15 Thousand USD | -21578398.528% |
| Warpaint London PLC | 21.97 Million USD | -321134.528% |
| Zoono Group Limited | 251.07 Thousand USD | -28117954.726% |
| Zurvita Holdings, Inc. | 4.17 Million USD | -1691895.712% |